Showing results (331-340 of 371) with videos related to
Sort By:
Pageof 38
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
Therapeutic effect of myogenic cells modified to express neurotrophic factors in a rat model of sciatic nerve injuryM Dadon-Nachum, T Ben-Zur, I Srugo, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 13, 2006
Skin biopsy for assessment of autonomic denervation in Parkinson's diseaseR Dabby, R Djaldetti, M Shahmurov, et al.Brain Research|January 22, 1993
Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluidH Goldberg-Stern, D Atlas, L Schwartz, et al.Molecular Oncology|March 13, 2025
Revisiting CDKN2A dysregulation in Ewing sarcomaAnjali Paragji, Vivek Shastri, Elham Nasri, et al.Pediatric Research|August 16, 2025
Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experimentBenjamin Q Duong, Nathan D Seligson, Kelsey J Cook, et al.JAMA Network Open|October 3, 2019
Common Secondary Genomic Variants Associated With Advanced Epithelioid HemangioendotheliomaNathan D Seligson, Achal Awasthi, Sherri Z Millis, et al.Pharmacogenomics|September 13, 2023
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancerNathan D Seligson, Jill M Kolesar, Benish Alam, et al.Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
The proto-oncogene Bcl-2 inhibits cellular toxicity of dopamine: possible implications for Parkinson's diseaseI Ziv, D Offen, R Haviv, et al.Journal of Neurosurgery. Pediatrics|May 2, 2025
Safety profile of intracranial neuromodulation for drug-resistant epilepsy in childrenShikha Singh, Caren Armstrong, Susan E Melamed, et al.Journal of Molecular Neuroscience : MN|April 17, 2001
Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE)D Offen, J F Kaye, O Bernard, et al.Pageof 38